Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Ceschi

Showing results (111-120 of 113) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 113 results.
Clinical Toxicology (Philadelphia, Pa.)|June 27, 2024
Clinical effects of cannabis compared to synthetic cannabinoid receptor agonists (SCRAs): a retrospective cohort study of presentations with acute toxicity to European hospitals between 2013 and 2020Mitchell L Waters, Paul I Dargan, Christopher Yates, et al.
Nature|August 30, 2023
Neutralization, effector function and immune imprinting of Omicron variantsAmin Addetia, Luca Piccoli, James Brett Case, et al.
Cell|February 23, 2021
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunityEmma C Thomson, Laura E Rosen, James G Shepherd, et al.
Pageof 12

Showing results (111-120 of 113) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 113 results.
Clinical Toxicology (Philadelphia, Pa.)|June 27, 2024
Clinical effects of cannabis compared to synthetic cannabinoid receptor agonists (SCRAs): a retrospective cohort study of presentations with acute toxicity to European hospitals between 2013 and 2020Mitchell L Waters, Paul I Dargan, Christopher Yates, et al.
Nature|August 30, 2023
Neutralization, effector function and immune imprinting of Omicron variantsAmin Addetia, Luca Piccoli, James Brett Case, et al.
Cell|February 23, 2021
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunityEmma C Thomson, Laura E Rosen, James G Shepherd, et al.
Pageof 12